Evolving Molecular Mechanism-Based Strategies for Control of Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|28|4375-4388

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.28, 2011-10, pp. : 4375-4388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 990-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibition of Zinc Proteases

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 959-965

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy

By  

Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. : 2432-2437

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Transport Mechanism-Based Drug Molecular Design: Novel Camptothecin Analogues to Circumvent ABCG2-associated Drug Resistance of Human Tumor Cells

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 313-325

Bentham Science Publishers

Access to resources Recommend Favorite